TMPRSS-4 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human TMPRSS4 (UniProt Q9NRS4), HEK293-expressed. Plasma membrane-anchored serine protease used in pro-uPA processing assays, inhibitor screens, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-TMPRSS4

In stock

SKU
REC-TMPRSS4
$498.00

Target Overview

TMPRSS4 (Transmembrane Protease Serine 4; UniProt Q9NRS4) is a type II transmembrane serine protease belonging to the matriptase/hepsin subfamily. The full-length human protein spans 437 amino acids and is anchored at the plasma membrane, where its extracellular catalytic domain executes trypsin-like proteolysis at basic residue sites. The catalytic chain is generated by autocatalytic or trans-proteolytic cleavage of the zymogen precursor. TMPRSS4 directly processes pro-urokinase plasminogen activator (pro-uPA/PLAU) into its active two-chain form, placing it upstream of the plasminogen activation cascade. It has also been implicated in epithelial sodium channel (ENaC) activation by functional analogy with other channel-activating proteases. This recombinant is produced in HEK293 cells, providing mammalian-type glycosylation and disulfide bond formation that are relevant to native enzyme conformation and catalytic competence. The HEK293 expression system is particularly appropriate for a glycoprotein of this class, where post-translational modifications influence folding and substrate recognition. Researchers use this recombinant in several contexts: direct substrate cleavage assays using pro-uPA or fluorogenic peptide substrates, inhibitor IC50 determinations with serine protease inhibitor libraries, and as a positive control antigen for Western blot and IHC validation of anti-TMPRSS4 antibodies. For antibody validation workflows, this recombinant pairs directly with the matched Triple Point Biologics antibody (RP-TMPRSS4), which has been validated for Western blot against human TMPRSS4, with predicted cross-reactivity to rat, pan, and dog. The defined, recombinant source eliminates lot-to-lot variability common with cell lysate standards, making it a reliable reference material for orthogonal validation experiments.

Background

TMPRSS4 is a plasma membrane-anchored serine protease with trypsin-like specificity, encoded by the TMPRSS4 gene on human chromosome 11q23.3. It belongs to the type II transmembrane serine protease (TTSP) family, a group of cell-surface proteases that regulate pericellular proteolysis without requiring secretion. The protease domain resides extracellularly and, following zymogen activation, cleaves substrates at basic residues (Arg/Lys) in a manner sensitive to canonical serine protease inhibitors such as aprotinin and benzamidine. The best-characterised substrate of TMPRSS4 is pro-urokinase plasminogen activator (pro-uPA), which it converts to the active single-chain and two-chain uPA species (PubMed:24434139). This positions TMPRSS4 as a cell-surface regulator of the uPA–uPAR axis, a proteolytic network extensively studied in the context of extracellular matrix remodelling, cell migration, and invasion. Because uPA activation occurs at the cell surface, TMPRSS4 has been investigated as a spatially restricted amplifier of pericellular plasminogen activation in epithelial tissues. TMPRSS4 expression has been characterised across multiple epithelial tumour types, including gastric and pancreatic cancers, where its expression level correlates with invasive phenotype in published transcriptomic and proteomic datasets. Tazawa et al. (2025) demonstrated that siRNA-mediated silencing of TMPRSS4 using lipid nanoparticle delivery reduced tumour growth in a human gastric cancer xenograft model, establishing TMPRSS4 as an experimentally tractable research target for studying protease-dependent cancer cell behaviour. Separately, TMPRSS4 has been identified in computational analyses of pancreatic ductal adenocarcinoma (PDAC) proteolytic signatures, and anti-TMPRSS4 autoantibodies have been explored in serum-based early detection panels for pancreatic cancer. Beyond oncology-related research, the functional analogy between TMPRSS4 and other channel-activating proteases (CAPs) such as CAP1/PRSS8 positions it as a candidate regulator of ENaC-dependent sodium transport in epithelial tissues, a relationship under active investigation in epithelial physiology models. Recombinant TMPRSS4 enables direct biochemical dissection of these activities — substrate selectivity profiling, inhibitor potency ranking, and structural studies — independently of endogenous expression context.

Applications

  • Pro-uPA cleavage activity assay to confirm catalytic competence of the recombinant preparation
  • Fluorogenic peptide substrate cleavage assay (e.g., Boc-Gln-Ala-Arg-AMC or tosyl-GPR-AMC) for kinetic parameter determination
  • Serine protease inhibitor IC50 determination by competitive or progress-curve methods
  • Substrate identification and cleavage-site mapping by mass spectrometry-based degradomics
  • Western blot positive control antigen for validation of anti-TMPRSS4 antibodies, including paired use with Triple Point Biologics antibody RP-TMPRSS4
  • IHC standard and blocking antigen control for anti-TMPRSS4 antibody specificity assessment
  • SPR or BLI-based binding affinity measurement of antibody or small-molecule interactions with the TMPRSS4 ectodomain
  • Reconstituted cell-free uPA activation assay to dissect the TMPRSS4–pro-uPA proteolytic axis

References

  1. Tazawa H et al. Delivery of lipid nanoparticles containing small interfering RNA targeting transmembrane serine protease 4 in a human gastric cancer model using nude mice. Sci Rep. 2025. doi:10.1038/s41598-025-32407-x. PMID: 41430089
  2. Sun L et al. Serum autoantibody signatures enable non-invasive early detection of pancreatic cancer. Pancreatology. 2026. doi:10.1016/j.pan.2025.11.017. PMID: 41314901
  3. Kamble P et al. Computational theranostics strategy for pancreatic ductal adenocarcinoma. Mol Divers. 2026. doi:10.1007/s11030-025-11241-3. PMID: 40522604

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type II transmembrane serine protease; cell surface

Frequently Asked Questions

What molecular weight band should I expect for recombinant TMPRSS-4 on SDS-PAGE or Western blot?

The full-length human TMPRSS-4 (UniProt Q9NRS4) has a predicted molecular weight of ~48 kDa from its 437-amino-acid sequence, but the HEK293-expressed recombinant typically migrates at ~55–60 kDa under denaturing conditions due to mammalian N-linked glycosylation. Under reducing versus non-reducing conditions the apparent MW should not shift dramatically, as the active catalytic fragment is generated by cleavage of the zymogen and may appear as a doublet near 30–35 kDa in preparations enriched for the processed form. Confirm your observed band using matched antibody RP-TMPRSS4 as a direct reference.

What processing form is the recombinant TMPRSS-4 supplied in — zymogen or active cleaved form?

REC-TMPRSS4 is supplied as the active enzyme. During HEK293 expression, TMPRSS4 undergoes autocatalytic or trans-proteolytic cleavage of its zymogen precursor, releasing the extracellular serine protease domain. The recombinant is produced and quality-controlled as this catalytically competent form rather than the uncleaved single-chain precursor. If your experimental model specifically requires the zymogen (e.g., to study activation kinetics), note that the supplied material will not reflect that unprocessed state and you should account for this in assay design.

What substrate should I use to measure TMPRSS-4 serine protease activity in a fluorescent activity assay?

TMPRSS4 is a trypsin-like serine protease that cleaves after basic residues (Arg, Lys). The most commonly used fluorogenic substrates are Boc-Gln-Ala-Arg-AMC and Tos-Gly-Pro-Arg-AMC (excitation ~380 nm, emission ~460 nm). For a standard kinetic assay, prepare 50–200 µM substrate in assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.01% Tween-20) and use 0.5–2 µg/mL REC-TMPRSS4. Monitor fluorescence continuously at 37°C. Include a serine protease inhibitor control (e.g., PMSF or aprotinin) to confirm signal specificity.

What buffer conditions are optimal for TMPRSS-4 recombinant enzyme activity and stability?

REC-TMPRSS4 is stored in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and is fully compatible with assay buffers in the pH 7.0–8.0 range. Avoid EDTA or chelating agents in activity assays, as some serine proteases are sensitive to metal depletion; however, TMPRSS4 is not a metalloprotease and does not require supplemental CaCl₂. Reducing agents such as DTT above 1 mM can compromise disulfide-dependent active-site geometry — keep them at ≤0.5 mM if required. For functional downstream assays involving pro-uPA cleavage, physiological pH (7.4) in HEPES- or Tris-buffered saline is appropriate.

What starting concentration of recombinant TMPRSS-4 should I use to cleave pro-uPA (PLAU) substrate in vitro?

For cleavage of recombinant pro-uPA (PLAU) into its active two-chain form, a reasonable starting point is 0.5–2 µg of REC-TMPRSS4 per 10 µg of pro-uPA substrate, incubated at 37°C for 60–120 minutes in 50 mM Tris-HCl pH 7.5, 150 mM NaCl. Resolve the reaction by non-reducing SDS-PAGE and probe with an anti-uPA antibody to confirm the ~54 kDa single-chain to ~33 kDa + ~18 kDa two-chain conversion. Titrate enzyme-to-substrate ratio empirically if your pro-uPA source differs in glycosylation or specific activity from recombinant standards.

Can I use recombinant TMPRSS-4 as a Western blot positive control for the RP-TMPRSS4 antibody?

Yes — REC-TMPRSS4 and RP-TMPRSS4 are produced and validated together in the same laboratory specifically for this purpose. Load 50–100 ng of REC-TMPRSS4 per lane alongside your cell or tissue lysate. The rabbit polyclonal RP-TMPRSS4 (see /anti-tmprss-4-rabbit-polyclonal-antibody) is validated for Western blot and should produce a clean band at ~55–60 kDa (glycosylated recombinant) that serves as an unambiguous size marker and signal-intensity reference. This pairing is particularly useful when validating the antibody in a new cell line or tissue context where endogenous TMPRSS4 expression is uncertain.

How much recombinant TMPRSS-4 should I load for a Western blot positive control lane?

50–100 ng per lane is sufficient for a strong, clean signal with RP-TMPRSS4 at a 1:1,000–1:2,000 primary antibody dilution, standard HRP-conjugated secondary, and ECL detection. At 50 ng you will see a clearly detectable band without overwhelming adjacent sample lanes; at 100 ng the band is robust enough to serve as a reliable reference even with shorter exposure times. Because REC-TMPRSS4 is supplied at >90% purity by SDS-PAGE with endotoxin <0.1 EU/µg, background from contaminants is minimal and will not confound band interpretation.

How should I handle and store recombinant TMPRSS-4 to preserve enzymatic activity over time?

REC-TMPRSS4 is shipped on dry ice and should be stored at -20°C immediately upon receipt. The storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) stabilizes the enzyme through freeze-thaw; however, repeated freeze-thaw cycles progressively reduce specific activity — aliquot into single-use volumes before freezing. On the day of use, thaw on ice and dilute into pre-warmed assay buffer immediately before the experiment. Do not store diluted enzyme at 4°C for more than 24 hours. For long-term storage beyond 6 months, verify activity with a fluorogenic substrate benchmark before committing to a critical experiment.

Validation imagery coming soon

Western blot validation figures for REC-TMPRSS4 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →